🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Spain / NCT07074964
Starting soon Not applicable

Manual Therapy in Vagus Nerve Neuromodulation for the Treatment of Bruxism

NCT07074964 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2025-10-01
Last updated
2025-07-24

Condition(s) studied

Bruxism, Sleep

Investigational drug(s) / intervention(s)

Autonomic nervous system interventionSlight finger pressure

Autonomic nervous system intervention: Manual therapy applied to structures adjacent to the vagus nerve along its pathway. Head: CV4 tecnique and Jugular foramen tecnique; Neck: stretching and mobilization of the superficial and deep layers; Thorax: Longitudinal and transverse translations of the mediastinum; Diaphragm tecniques, Abdomen: Stretching of the gastro-phrenic ligament with lowering of the stomach and general treatment of the small intestine and the mesentery. Stretching, compression and traction movements will be carried out on these structures.

Slight finger pressure: The hands will be placed on areas similar to those in the intervention group, with the fingertips in contact with the skin of the area. A slight finger pressure will be applied, which would not have the same effect as the proposed techniques, since those techniques require a greater intensity of manipulation of the described tissues and structures.

Study summary

Introduction:

Sleep bruxism is defined as the repetitive activity of the masticatory muscles, characterized by clenching or grinding of the teeth. Studies confirm the association between sleep bruxism and episodes of masticatory muscle activity, with an increase in autonomic sympathetic activity observed during transient periods of sleep. This is associated with nocturnal awakenings, related to increased cardiac, cerebral (cortical arousal), respiratory, and muscular activity.

Objectives: The main objectives are "To study the mean power frequency (MPF) of the masticatory muscles measured by surface electromyography (sEMG) in the general population (with and without bruxism according to ICSD-3 and DC/TMD criteria)"; and "to assess the effectiveness of manual therapy applied to structures adjacent to the vagus nerve based on its impact on orofacial pain and symptomatology in patients with bruxism".

Material and Methods:

A cross-sectional observational study and a randomized controlled experimental study were designed. The first will analyze data collected by sEMG in the masticatory muscles, at rest and during maximum clenching, comparing results between bruxists and non-bruxists. The second will analyze, compared to the control group, data collected on signs (range of motion alteration, presence of sounds), symptomatology (pain, headaches, sensation of blockage, functional limitation) caused by bruxism, sleep quality (Pittsburgh Sleep Quality Index (PSQI)), oral health-related quality of life (OHIP-14), stress and anxiety status (Perceived Stress Scale and GAD-7 (Generalized Anxiety Disorder-7), respectively), and sympathetic-vagal balance (Heart Rate Variability in its frequency and time domains) before and after a manual therapy intervention on structures adjacent to the vagus nerve pathway (head, neck, thorax, diaphragm, abdomen). The collected data will be analyzed using IBM SPSS® version 25.0.0.

Eligibility

Sex
ALL
Min age
18 Years
Max age
40 Years
Healthy volunteers
No
Inclusion Criteria: 1. Sleep bruxism diagnosed according to the ICSD-III (International Classification of Sleep Disorders, 3rd edition): * Regular or frequent tooth grinding sounds occurring during sleep and the presence of one or more of the following clinical signs and symptoms: 1. Abnormal tooth wear consistent with reports of clenching/grinding the teeth during sleep 2. Transient morning pain or fatigue in the jaw muscles; and/or temporal headaches; and/or jaw locking upon awakening, consistent with reports of clenching/grinding the teeth during sleep 2. Sleep bruxism diagnosed according to the RDC/TMD: * Interview: During the interview, subjects are asked about the following symptoms: reports of regular or frequent tooth grinding during sleep, muscle fatigue, temporal headache, transient morning muscle pain in the jaw, and jaw locking upon awakening. * Physical examination: Presence or signs suggesting abnormal dental wear, such as teeth with flattened cusps and/or loss of contour with dentin exposure. * Hypertrophy of the masticatory muscles * Dental impressions on the tongue * Linea alba on the cheeks along the bite line * Damage to dental tissue * Excessive dental wear 3. A minimum pain intensity score of 3 on the Visual Analogue Scale at the masseter and temporal algometry points. 4. EMGs with elevated mean power frequency for the masseter and temporalis muscles (to be defined in the first clinical phase-observational study). 5. Age between 18 and 40 years. Exclusion Criteria: 1. Having suffered direct trauma, mandibular fractures, or surgeries in the orofacial region. 2. Loss of more than 2 teeth, except for the third molar. 3. Use of muscle relaxant medication or medications that may influence motor behavior. 4. Having received botulinum toxin treatment in the last 6 months. 5. Periodontal disorders or current orthodontic treatment or prosthesis. 6. Partial or total dentures. 7. History of medical disorders (severe psychiatric, physiological, or neurological conditions).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Universitat International de Catalunya (UIC) Sant Cugat del Vallès Barcelona

More Escoles Universitaries Gimbernat trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07074964 on ClinicalTrials.gov ↗ ← All trials in Spain